Ketamine for the acute treatment of severe suicidal ideation: double blind, randomised placebo controlled trialMocrane Abbar, Fabrice Jollant, Pascale Fabbro-Péray et al.|BMJ|2022Cited by 177
Does long-acting injectable risperidone make a difference to the real-life treatment of schizophrenia? Results of the Cohort for the General study of Schizophrenia (CGS)Lamiae Grimaldi‐Bensouda, Lucien Abenhaim, Frédéric Rouillon et al.|Schizophrenia Research|2011Cited by 90
Morningness<i>–</i>eveningness and treatment response in major depressive disorderEmmanuelle Corruble, Philip Gorwood, Ellen Frank et al.|Chronobiology International|2013Cited by 44
Is it worth assessing progress as early as week 2 to adapt antidepressive treatment strategy? Results from a study on agomelatine and a global meta-analysisPhilip Gorwood, Pierre‐Michel Llorca, Franck Baylé et al.|European Psychiatry|2013Cited by 31
Telephone-administered psychotherapy in combination with antidepressant medication for the acute treatment of major depressive disorderEmmanuelle Corruble, Philip Gorwood, Holly A. Swartz et al.|Journal of Affective Disorders|2015Cited by 25